Elanco Animal Health Inc represents a strong commitment to improving animal health and welfare. Their corporate philosophy is rooted in the belief that healthy animals contribute to a better world for both animals and humans. They strive to deliver innovative solutions and products that address the diverse needs of animals, including their nutrition, health, and well-being. Elanco Animal Health Inc is dedicated to ensuring the responsible and ethical use of their products, while providing exceptional value to their customers. They aim to foster strong partnerships within the animal health industry and continuously work towards advancements in animal care and sustainability.

Elanco Animal Health Inc is primarily present in multiple countries and regions worldwide. As a global company, Elanco operates in various parts of North America, including the United States and Canada. It also maintains a significant presence in Europe, with operations in several countries such as Germany, France, Spain, Italy, and the United Kingdom. Additionally, Elanco has a strong foothold in the Asia-Pacific region, with a focus on countries like China, Japan, Australia, and India. The company's broad international presence allows Elanco Animal Health Inc to cater to the diverse needs of animal health across different markets, showcasing its commitment to global growth and innovation.

Elanco Animal Health Inc has achieved several significant milestones in its history. Since its inception, the company has focused on improving animal health through its innovative products and solutions. One major milestone was its spin-off from Eli Lilly and Company in 2018, establishing Elanco as a standalone company dedicated solely to animal health. Elanco has continually expanded its portfolio of products and services, helping to address the diverse needs of farmers and veterinarians worldwide. Through strategic acquisitions and collaborations, the company has strengthened its position in the animal health industry. Moreover, Elanco's commitment to sustainability and responsible animal care has garnered recognition, earning it a place among the industry leaders.

Elanco Animal Health Inc, a leading animal health company, has a rich history and background. Established in 1954 as a division of Eli Lilly and Company, Elanco has grown into a standalone company dedicated to improving animal health and well-being. With a wide portfolio of products and services, Elanco offers solutions for livestock and pets, encompassing pharmaceuticals, vaccines, and medicated feed additives. The company's commitment to innovation and research has positioned it as a global leader in animal health, addressing the evolving needs of the industry. Elanco Animal Health Inc continues to advance animal health through sustainable practices and partnerships, ensuring healthier and happier animals worldwide.

The main competitors of Elanco Animal Health Inc in the market include Zoetis Inc, Merck Animal Health, and Boehringer Ingelheim.

Elanco Animal Health Inc is primarily active in the animal health industry.

The business model of Elanco Animal Health Inc is focused on providing comprehensive solutions for animal health and welfare. Elanco develops and manufactures a wide range of pharmaceutical products, vaccines, and nutritional products for both companion animals and livestock. The company aims to improve the health and well-being of animals by delivering innovative solutions that enhance their productivity and quality of life. Elanco's business model operates through research and development, manufacturing, marketing, and sales of animal health products globally. With a commitment to innovation and sustainability, Elanco Animal Health is dedicated to supporting the welfare of animals and the needs of their owners.

Elanco Animal Health의 P/E 비율은 15.46입니다.

Elanco Animal Health의 P/S 비율은 1.58입니다.

Elanco Animal Health에 대한 AlleAktien 품질 점수는 2/10입니다.

예상되는 Elanco Animal Health 매출은 4.51 조. USD입니다.

예상되는 Elanco Animal Health 이익은 460.69 백만 USD입니다.

Elanco Animal Health Inc. is a global company that focuses on researching, developing, manufacturing, and marketing products and solutions for animal health. The company offers a wide range of products in the areas of animal health, animal nutrition, and animal production, and serves customers in over 90 countries worldwide.

Elanco Animal Health은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Elanco Animal Health의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Elanco Animal Health의 ISIN은 US28414H1032입니다.

Elanco Animal Health의 WKN은 A2N6BH입니다.

Elanco Animal Health의 티커는 ELAN입니다.

지난 12개월 동안 Elanco Animal Health은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Elanco Animal Health은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Elanco Animal Health의 현재 배당 수익률은 입니다.

Elanco Animal Health은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Elanco Animal Health은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Elanco Animal Health은 '건강' 섹터에 속합니다.

Elanco Animal Health의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Elanco Animal Health는 0 USD를 배당금으로 지급했습니다.

Elanco Animal Health의 배당금은 USD에 지급됩니다.